Related Experiment Video
Updated: May 10, 2025
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
15.9K
Why Dosing Matters: A Closer Look at the Dose-Response Relationship With OnabotulinumtoxinA
Wolfgang G Philipp-Dormston1,2, John H Joseph3, Jean D A Carruthers4
1Hautzentrum Köln, Cologne, Germany.
Journal of Cosmetic Dermatology
|April 26, 2025
Summary
Appropriate dosing of onabotulinumtoxinA (Botox) for upper facial lines is crucial. Using the licensed dose ensures optimal results and patient satisfaction, while underdosing leads to poorer outcomes.
Area of Science:
- Aesthetic medicine
- Dermatology
- Neuromodulator treatments
Background:
- OnabotulinumtoxinA is approved for treating glabellar, lateral canthal, and forehead lines.
- Standard doses are 20U (glabella), 24U (lateral canthal), and 20U (forehead).
Purpose of the Study:
- To evaluate the dosing science and dose-response relationship of onabotulinumtoxinA for upper facial lines (UFL).
Main Methods:
- Analysis of available data to address practical dosing questions.
- Review of Phase 3 registrational trial data and clinical practice observations.
Main Results:
- Licensed doses ensure optimal efficacy, duration, and patient satisfaction for UFL treatment.
- Underdosing onabotulinumtoxinA results in shorter duration and reduced efficacy.
- Higher doses may improve outcomes without compromising safety, particularly in the glabella.
Conclusions:
- Optimal onabotulinumtoxinA dosing is vital for maximizing treatment benefits and patient satisfaction.
- Further research is needed on dose-response in specific facial areas and potential ceiling doses.
Related Concept Videos
01:03Dose-Response Relationship: Overview
2.8K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.8K
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
622
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
622
01:22Dose-Response Relationship: Potency and Efficacy
4.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.0K
01:14Agonism and Antagonism: Quantification
255
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
255
01:25Dose-Response Relationship: Selectivity and Specificity
6.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.2K
01:19Depolarizing Blockers: Pharmocokinetics
289
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
289